Navigation Links
Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
Date:3/4/2009

964 812,622 4,268,121 ------------------------------------------------------------------------- Cash used in operating activities (15,288,632) (14,422,092) (12,997,981) (88,204,848) ------------------------------------------------------------------------- INVESTING ACTIVITIES Acquisition of property and equipment (111,577) (92,221) (35,838) (813,744) Purchase of short-term investments (347,901) (949,496) (1,035,427) (49,416,864) Redemption of short-term investments 13,000,000 6,573,000 13,808,000 43,151,746 Investment in BCY LifeSciences Inc. - - - 464,602 Investment in Transition Therapeutics Inc. - - - 2,532,343 ------------------------------------------------------------------------- Cash provided by (used in) investing activities 12,540,522 5,531,283 12,736,735 (4,081,917) ------------------------------------------------------------------------- FINANCING ACTIVITIES Proceeds from exercise of stock options and warrants 41,600 51,000 241,400 15,301,068 Proceeds from private placements - - - 38,137,385 Proceeds from public offerings 3,421,309 12,063,394 - 46,278,207 ------------------------------------------------------------------------- Cash provided by financing activities 3,462,909 12,114,394 241,400 99,716,660 ------------------------------------------------------------------------- Net increase (decrease) in cash and cash equivalents during the period 714,799
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... City, CA (PRWEB) August 28, 2014 ... sanitation products for the food processing industry, is asking ... a side-by side comparison of the E2 soap they’re ... E2 Sanitizing Foam Soap . Hand hygiene is ... in the food processing environment. Six key criteria are ...
(Date:8/28/2014)... 2014 “This kit has an improved extraction ... 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product ... to plant owners and USDA-GIPSA inspection agencies that have a ... can take place in a matter of minutes with nothing ... test the feed and grain before accepting it, but they ...
(Date:8/28/2014)... important devices in spintronics, an electronic which is ... but also on their spin and the spin-related ... into magnetic signals and vice versa. Recently, the ... Institute of Physics at Johannes Gutenberg University Mainz ... and Japan, has for the first time realised ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 The ... create a culture that will allow individuals to perform ... becoming increasingly important for employers looking to compete in ... industries are embracing this trend, as the sector increasingly ... of a company, which will have real results on ...
Breaking Biology Technology:Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2A new, tunable device for spintronics 2A new, tunable device for spintronics 3Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3
... (Nasdaq: CRTX ), a specialty pharmaceutical company ... for the respiratory market, today announced that Craig A. ... a corporate overview at BioCentury,s 16th Annual Future Leaders ... on Thursday, April 2, 2009, at the Millennium Broadway ...
... March 31 One of the nation,s ... the region,s scientific assets align to support the critical ... develop urgently needed bioenergy solutions. , ... today that they are expanding MRI,s existing operations by ...
... funded by Cadila Pharmaceuticals and Revenues from Sales ... in Novavax , ROCKVILLE, Md., March 31 ... today it has formed a joint venture with ... and market vaccines, pharmaceuticals and diagnostic products in ...
Cached Biology Technology:Cornerstone Therapeutics to Present at BioCentury's 2009 Future Leaders in the Biotech Industry Conference 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 3Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 4Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 2Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 3Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 4Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 5Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 6
(Date:8/31/2014)... greatest challenges in modern medicine is developing drugs that ... toxicity and side-effects to the patient. Such properties are ... molecule. Ideally, the drug should have a shape that ... it binds it with high specificity. Publishing in ... amino acid that can impact the 3D structure of ...
(Date:8/31/2014)... satellite data from the last 19 years reveals that fresh ... coast of Antarctica to rise by 2cm more than the ... Southampton detected the rapid rise in sea-level by studying satellite ... square kilometres. , The melting of the Antarctic ... contributed an excess of around 350 gigatonnes of freshwater to ...
(Date:8/31/2014)... MA -- Over the past several decades, malaria diagnosis has ... patient, a technician smears the blood across a glass slide, ... microscope for the Plasmodium parasite, which causes the disease. This ... in the blood an important measure of disease severity ... human error. , A research team from the Singapore-MIT Alliance ...
Breaking Biology News(10 mins):A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3A new way to diagnose malaria 2A new way to diagnose malaria 3
... DURHAM, N.C. By reproducing in the laboratory the complex ... Duke University bioengineers have created a system they believe can ... biology. This new approach should help basic scientists as ... off" many different genes, as well as clinicians seeking to ...
... Pa. Sound waves are widely used in medical imaging, ... fetus. Now scientists have developed a way to use sound ... the University of Bordeaux in France deployed high-frequency sound waves ... individual human cells. The scientists predict that the probe could ...
... Philadelphia, Pa. With the discovery of antibiotics, medicine ... protect health, save lives, and reduce suffering caused by ... under siege because some virulent infections no longer respond ... an urgent public health threat that a team of ...
Cached Biology News:Recreating natural complex gene regulation 2Listening to cells: Scientists probe human cells with high-frequency sound 2Tracking the evolution of antibiotic resistance 2
... single use spatulas have been designed to ... are for those interested in eliminating the ... Each spatula is individually packaged, RNase/DNase free, ... is a new product number, created to ...
... of cells • Blade design minimizes cell ... growth surface • Designed for use in ... • Sterilized by gamma radiation and certified ... new product number, created to easily match ...
... Corning single use spatulas have been ... samples. They are for those interested in ... reusable spatulas. Each spatula is individually packaged, ... CLS number is a new product number, ...
... The MagneGST™ Protein Purification System provides ... for the purification of glutathione-S-transferase (GST) ... (MagneGST™ Particles) are used to isolate ... or cleared lysate using either a ...
Biology Products: